Lantern Pharma Inc. Own-share Lending Arrangement, Shares, Issued
Lantern Pharma Inc. (LTRN) had Own-share Lending Arrangement, Shares, Issued of 8.32 thousand shares as of 2021-12-31, per its 10-K filed 2022-03-10.
Discontinued › Notes › Debt
us-gaap:OwnshareLendingArrangementSharesIssued · last filed 2022-05-03
- 2021-12-31: Own-share Lending Arrangement, Shares, Issued 8.32K shares.
- 2021-03-31: Own-share Lending Arrangement, Shares, Issued 800.00 shares.
| Period end | Own-share Lending Arrangement, Shares, Issued |
|---|---|
| 2021-12-31 | 8.32K shares 10-K · filed 2022-03-10 |
| 2021-03-31 | 800.00 shares 10-Q · filed 2022-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |